| Literature DB >> 15454232 |
John G Cumming1, Caroline L McKenzie, Stuart G Bowden, Douglas Campbell, David J Masters, Jason Breed, Philip J Jewsbury.
Abstract
SAR studies led to the identification of 4-(3-benzoylamino-6-methyl-anilino)quinazolines as potent and selective inhibitors of p38 MAP kinase. Further optimisation led to the identification of a series of 4-(3-benzoylamino-6-methyl-anilino)pyrimidines as potent inhibitors of the p38 MAP kinase signalling pathway in vitro and in vivo.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15454232 DOI: 10.1016/j.bmcl.2004.08.007
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823